Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NDUFB4P5 is a human pseudogene annotated as NADH:ubiquinone oxidoreductase subunit B4 pseudogene 5. Pseudogenes are genomic DNA sequences similar to functional genes but typically do not produce functional protein products. This pseudogene is part of a family related to mitochondrial complex I subunits but, as with most pseudogenes, does not encode an active protein or play a direct role in cellular metabolism[1][3][5][6]. There is no evidence for a therapeutic, diagnostic, or biomarker role. While research on pseudogenes suggests possible regulatory activities (e.g., in cancer or other diseases through non-coding RNA functions), there is no direct evidence NDUFB4P5 has such functional impact[4]. \n\nOverall, NDUFB4P5 is a non-coding pseudogene and not a receptor, enzyme, transporter, or therapeutic target. Its main role is as an annotated genomic sequence, without known biological, disease-related, or pharmacological significance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NADH:ubiquinone oxidoreductase subunit B4 pseudogene 5 (NDUFB4P5).